V008-2992 Screening compound: N-benzyl-N-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl]-2-[N-(3-methylbutyl)4-methylbenzenesulfonamido]acetamide

V008-2992 Screening compound: N-benzyl-N-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl]-2-[N-(3-methylbutyl)4-methylbenzenesulfonamido]acetamide
V008-2992 Screening compound: N-benzyl-N-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl]-2-[N-(3-methylbutyl)4-methylbenzenesulfonamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-2992
N-benzyl-N-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl]-2-[N-(3-methylbutyl)4-methylbenzenesulfonamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-2992

Molecular Formula

C32H36N2O5S (C32 H36 N2 O5 S)

Compound Name

N-benzyl-N-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl]-2-[N-(3-methylbutyl)4-methylbenzenesulfonamido]acetamide

IUPAC name

N-benzyl-N-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl]-2-[N-(3-methylbutyl)4-methylbenzenesulfonamido]acetamide

SMILES

CC(C)CCN(CC(N(Cc1ccccc1)CC1=COc(ccc(C)c2)c2C1=O)=O)S(c1ccc(C)cc1)(=O)=O

InChI

InChI=1S/C32H36N2O5S/c1-23(2)16-17-34(40(37,38)28-13-10-24(3)11-14-28)21-31(35)33(19-26-8-6-5-7-9-26)20-27-22-39-30-15-12-25(4)18-29(30)32(27)36/h5-15,18,22-23H,16-17,19-21H2,1-4H3

InChI Key

DSSUGBYRMVMBDD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19770126

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

560.71

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.891

Distribution Coefficient, logD

5.891

Water Solubility, LogSw

-5.48

Polar Surface Area

68.169

Acid Dissociation Constant (pKa)

21.86

Base Dissociation Constant (pKb)

-6.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.30

V008-2992 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V008-2992 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-2992?
Check Price and Availability of V008-2992, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-2992 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-2992
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-2992
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-2992 available by request